DDX53 and neoplasm: Comparative analysis with the mock group revealed significant suppression of tumor growth in the LD‐EM group, with TGI rates of 59.9%, 77.3%, and 62.6% in CT26, HNM007, and AKR mice, respectively (both p < 0.05) (Figure 1A,C,D).